|
Table of Contents:
Preface pp. i-xviii
Introduction
(Tom F. Parker, III)
1. Milestones in Dialysis;pp. 1-33
(Stephen Z. Fadem, Baylor College of Medicine, Houston, Texas USA and others)
2. The Course of Therapy – Changing the Paradigm;pp. 35-47
(Thomas A. Golper and Martin J. Schreiber, Jr.,Vanderbilt University Medical Center, Nashville, Tennessee, USA and others)
3. Accept this Kidney or Continue Dialysis? A Strategic Approach to Donor Options;pp. 49-64
(Amy L. Friedman, SUNY Upstate Medical University, Syracuse, New York, USA
4. Dialysis at Home - The Seattle Experience;pp. 65-83
(Chris Blagg, University of Washington, Seattle, USA and others
5. How do Clinical Outcomes of Automated Peritoneal Dialysis Compare with those of Continuous Ambulatory Peritoneal Dialysis?;pp. 85-102
(Sunil V. Badve, Carmel M. Hawley and David W. Johnson, Dept. of Nephrology, Princess Alexandra Hospital, Brisbane, Australia and others)
6. Intensified Hemodialysis Programs for Children and Adolescents;pp. 103-112
(Julia Thumfart and Dominik Müller, Dept. of Pediatric Nephrology, Charite Augustenburger Platz, Berlin, Germany)
7. The Wearable Artificial Kidney – A Paradigm Change in the Treatment of ESRD;pp. 113-122
(Victor Gura, Cedars Sinai Medical Center, Beverly Hills, California, USA)
8. Is Dialysis Ever An Inappropriate Therapy?;pp. 123-133
(Susan Higley Bray, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA)
9. The Pre-eminent Role for Control of Extra-cellular Volume in Dialysis Therapy;pp. 135-148
(Richard J. Glassock, Geffen School of Medicine at UCLA, California, USA)
10. Mechanisms causing Muscle Wasting in Kidney Disease and other Catabolic conditions;pp. 149-166
(William E. Mitch, Nephrology Division, Baylor College of Medicine, Houston, Texas, USA
11. The Dysregulated Immune System of Patients on Dialysis;pp. 167-192
(Alexander Grabner, Hermann Pavenstädt, Detlef Lang and Stefan Reuter, Dept. of Medicine D, University of Munster, Germany)
12. Is Serum Albumin a Useful Marker of Nutritional Status in Chronic Kidney Disease?;pp. 193-206
(Allon N. Friedman, Division of Nephrology, Indiana University School of Medicine, Indianapolis, USA)
13. The Chronic Kidney Disease-Mineral Bone Disorder (CKD-MBD) and Vascular Calcification;pp. 207-220
(Keith A. Hruska, YifuFang and Toshifumi Sugatani, Washington University School of Medicine, St. Louis, Missouri, USA)
14. Update on Anemia and Kidney Disease;pp. 221-250
(Kiran M Goli, Arkadiy Pinkhasov, Daniel L Landry, Yossi Chait, Joseph Horowitz, Christopher V Hollot, Rajiv P Shrestha and Michael J Germain, Baystate Medical Center, University of Massachusetts at Amherst, USA and others)
15. Accumulation of Toxic Metals and Trace Elements in Chronic Dialysis Patients;pp. 251-264
(Tzung-Hai Yen, Dan-Tzu Lin-Tanand, Ja-Liang Lin, Chang Gung Memorial Hospital, Taipei, Taiwan)
16. Adequacy of Dialysis;pp. 265-294
(James Tattersall, Leeds Teaching Hospitals, UK)
17. The AV Fistula;pp. 295-308
(Fahad A. Syed and Eric K. Peden, The Methodist Hospital, Houston, TX, USA)
18. Cardiac Surgery in the End Stage Renal Disease Population:General Considerations, Risk Factors and Clinical Outcomes;pp. 309-319
(Javier E. Anaya-Ayala, Mark G. Davies and Michael J. Reardon,Methodist DeBakey Heart and Vascular Center, The Methodist Hospital, Houston, TX, USA and others)
19. Assessing Heath-Related Quality of Life with the KDQOL-36;pp. 321-330
(Dori Schatell, Executive Director, Medical Education Institute, Inc., Madison, Wisconsin, USA)
20. Integrated Renal Disease Care;pp. 331-340
(Franklin W. Maddux, Fresenius Medical Care Waltham, Massachusetts, USA)
Index pp. 341-361 |
